Antidote Technologies

🗓 Founded 2010👥 25 employees💰 Last funded Jun 2021
Research Services🌐 antidote.me
Website LinkedIn
Antidote is on a mission to catalyze medical innovation by successfully connecting patients and researchers as the best-in-class recruiter for clinical studies. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. Were based in New York, NY and London, U.K. For more information, visit http://www.antidote.me.
6
Total investors
1
Early stage
2
Mid stage
2
Late stage
2010
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United Kingdom
4
Spain
1
France
1
Investor activity2011–2021 · investors recorded per year
2011120152201712019120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Antidote Technologies?
Antidote Technologies has 6 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage and 2 late-stage investors.
When did Antidote Technologies last raise funding?
The most recent investment in Antidote Technologies recorded on gritt.io was in June 2021.
When was Antidote Technologies founded?
Antidote Technologies was founded in 2010.
What industry is Antidote Technologies in?
Antidote Technologies operates in Research Services. Find similar Research Services investors on gritt.io.
Where is Antidote Technologies based?
Antidote Technologies is headquartered in North Miami Beach.